Cytotoxic and Antimetastatic Activity of Hesperetin and Doxorubicin Combination Toward Her2 Expressing Breast Cancer Cells

OBJECTIVE: This study aimed to explore Hesperetin (Hst) potency as a co-chemotherapeutics agent combined with Doxorubicin (Dox), particularly cytotoxic and antimetastasis effects toward MCF-7/HER2 cells. METHODS: The cytotoxic effects were measured under MTT assay. The flowcytometry analysis was use...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Asian Pac J Cancer Prev
Autors principals: Nurhayati, Ika Putri, Khumaira, Annisa, Ilmawati, Gagas Pradani Nur, Meiyanto, Edy, Hermawan, Adam
Format: Artigo
Idioma:Inglês
Publicat: West Asia Organization for Cancer Prevention 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541862/
https://ncbi.nlm.nih.gov/pubmed/32458631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2020.21.5.1259
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars